Correlation Between Healthequity and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Healthequity and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Healthequity and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Healthequity and Allovir, you can compare the effects of market volatilities on Healthequity and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Healthequity with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Healthequity and Allovir.

Diversification Opportunities for Healthequity and Allovir

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Healthequity and Allovir is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Healthequity and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Healthequity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Healthequity are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Healthequity i.e., Healthequity and Allovir go up and down completely randomly.

Pair Corralation between Healthequity and Allovir

Considering the 90-day investment horizon Healthequity is expected to generate 1.73 times less return on investment than Allovir. But when comparing it to its historical volatility, Healthequity is 2.71 times less risky than Allovir. It trades about 0.17 of its potential returns per unit of risk. Allovir is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  726.00  in Allovir on July 5, 2022 and sell it today you would earn a total of  63.00  from holding Allovir or generate 8.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Healthequity  vs.  Allovir

 Performance (%) 
       Timeline  
Healthequity 
Healthequity Performance
8 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Healthequity are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Healthequity showed solid returns over the last few months and may actually be approaching a breakup point.

Healthequity Price Channel

Allovir 
Allovir Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Allovir reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir Price Channel

Healthequity and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Healthequity and Allovir

The main advantage of trading using opposite Healthequity and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Healthequity position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Healthequity vs. Amazon Inc
The idea behind Healthequity and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. BRP Inc
Allovir vs. Polaris Industries
Allovir vs. Arcimoto
Allovir vs. Harley-Davidson
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go